Cardlytics (CDLX) Asset Writedowns and Impairment (2017 - 2026)

Cardlytics has reported Asset Writedowns and Impairment for 10 years, with the latest figure at $335000.0 in Q1 2026.

• For the quarter ending Q1 2026, Asset Writedowns and Impairment fell 47.9% year-over-year to $335000.0; the trailing twelve-month figure through Mar 2026 stood at $3.7 million (down 97.28% YoY), and the FY2025 full-year result was $2.1 million, down 98.38% from the prior year.
• Asset Writedowns and Impairment for Q1 2026 stood at $335000.0, up from -$56.7 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $131.6 million in Q3 2024, with the low at -$56.7 million in Q4 2025.
• Historically, Asset Writedowns and Impairment has averaged $13.3 million across 5 years, with a median of $842500.0 in 2022.
• Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment slumped 171.1% — and 2024, when it soared 32074.82%.
• Cardlytics' Asset Writedowns and Impairment stood at $1.4 million in 2022, then soared by 4683.79% to $69.4 million in 2023, then surged by 89.71% to $131.6 million in 2024, then plunged by 143.09% to -$56.7 million in 2025, then jumped by 100.59% to $335000.0 in 2026.
• The last three Asset Writedowns and Impairment figures came in at $335000.0 (Q1 2026), -$56.7 million (Q4 2025), and $58.8 million (Q3 2025), per Business Quant data.